NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen
Toxicological Sciences · 2025
DOI: 10.1093/toxsci/kfaf034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Nyera A Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Summer Research Internship Program, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States. Hauptthemen laut MEDLINE: Acetaminophen, Brain, Benzoquinones, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, PharmAla Biotech, Inc., NIH HHS.
Abstract (Originalsprache)
Acetaminophen (APAP) is the most-used over-the-counter analgesic among pregnant women. However, concerns have arisen over the safety of APAP exposure during gestation. In particular, it’s been speculated that the hepatotoxic metabolite of APAP, N-acetyl-p-benzoquinone imine (NAPQI), forms in the brain after maternal use of therapeutic APAP doses and leads to neurodevelopmental disorders (NDDs). However, APAP metabolism in the brain is understudied. Here, we tested the hypothesis that NAPQI can be generated in the brain by overdosing BTBR T+ Itpr3tf/J (common model of the NDD autism) and C57Bl/6J mice with APAP and measuring glutathione loss and APAP-protein adducts as two of the best markers of NAPQI available. Despite glutathione depletion and adducts in the liver, we saw none in the brain. We conclude NAPQI is unlikely to contribute to the pathophysiology of NDDs. It has been hypothesized that NAPQI formation in the brain provides biological plausibility for the purported link between APAP and NDDs. Our results cast doubt on that hypothesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Summer Research Internship Program, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
- Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
- Acetaminophen Toxicity Diagnostics, LLC, Little Rock, AR 72205, United States.
- Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
- Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
- Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
ORCID-Profile: Mitchell R McGill
Förderung
- NIDDK NIH HHS
- PharmAla Biotech, Inc.
- NIH HHS
- US Department of Justice
- US Drug Enforcement Agency
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Ali, N. A., Kennon-McGill, S., Parker, L. D., James, L. P., Fantegrossi, W. E., & McGill, M. R. (2025). NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf034
Vancouver
Ali NA, Kennon-McGill S, Parker LD, James LP, Fantegrossi WE, McGill MR. NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf034
BibTeX
@article{Ali2025,
author = {Ali, Nyera A and Kennon-McGill, Stefanie and Parker, Larry D and James, Laura P and Fantegrossi, William E and McGill, Mitchell R},
title = {NAPQI is absent in the mouse brain after sub-hepatotoxic and hepatotoxic doses of acetaminophen},
journal = {Toxicological Sciences},
year = {2025},
doi = {10.1093/toxsci/kfaf034}
}
EUVIMED